SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for ...

Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of strategic investments to expand and enhance its radiochemistry, cell assays, ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Uniform picoliter volume droplets (picodroplets) may be produced with the use of microfluidic devices with accurate flow control and well-defined microchannel geometries. These picodroplets can be ...

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory ...

Companion diagnostics (CDx) are vital to precision oncology, enabling clinicians to match patients with therapies based on personalized factors such as biomarker profiles. However, traditional CDx ...

(RTTNews) - Agilent Technologies Inc. (A) said that it has partnered with Akoya Biosciences Inc. (AKYA) to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to ...

A good bioassay, like a good marriage, joins two partners in a bond and is mutually beneficial. In the case of bioassays, optimal design and development and accurate statistical analysis comprise a ...

Evasion of cell death is a hallmark of cancer cells that enables them to overcome endogenous barriers to cancer development and to resist treatment. Insights into the many facets of cell death, ...